Trial Profile
Open Label Study of the Effect of GTx-758 on Serum PSA and Free Testosterone Levels in Men With Castration Resistant Prostate Cancer and Maintained on Androgen Deprivation Therapy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2023
Price :
$35
*
At a glance
- Drugs GTx 758 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors GTx
- 04 Apr 2012 Planned end date (1 Sep 2013) added as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual patient number 8 added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from suspended to discontinued.